Vaccine News and Research

Latest Vaccine News and Research

Seniors should have the flu jab this winter, say experts

Despite recent doubts about its effectiveness, the influenza vaccine does give valuable protection against illness, hospital admission and death caused by influenza, and people over 65 should have the flu jab this winter, say experts on bmj.com.

18 Nov 2008

Vaccine-related chronic fatigue syndrome in an individual demonstrating aluminium overload

A team of scientists have investigated a case of vaccine-associated chronic fatigue syndrome (CFS) and macrophagic myofasciitis in an individual demonstrating aluminium overload.

18 Nov 2008

NCI sponsors Canadian cold/flu remedy trial in leukemia patients

Cancer patients, with their weakened immune systems, are particularly vulnerable when the cold and flu season hits. The National Cancer Institute (NCI), part of the National Institutes of Health and the world's most prestigious cancer research body, is sponsoring a landmark trial to evaluate if a unique Canadian cold remedy - ginseng extract COLD-FX - can help.

18 Nov 2008

One in four Gulf war veterans suffers from illness caused by toxic exposure

At least one in four of the 697,000 U.S. veterans of the 1991 Gulf War suffer from Gulf War illness, a condition caused by exposure to toxic chemicals, including pesticides and a drug administered to protect troops against nerve gas, and no effective treatments have yet been found, a federal panel of scientific experts and veterans concludes in a landmark report released Monday.

17 Nov 2008

Governments urged to take broader perspective when considering whether to fund vaccines

Including quality-of-life impacts in assessments of national vaccination programs would lead to many benefits, including improved productivity and less sick leave for parents, according to an editorial co-authored by a University of New South Wales (UNSW) researcher, that has appeared in the Lancet Infectious Diseases.

17 Nov 2008

Researchers say identifying women with HPV types 16, 18 and 45 could improve early intervention to stop cervical cancer

As testing for high-risk types of the human papillomavirus (HPV) emerges as the gold standard in cervical cancer prevention, scientists are already researching how to determine even more precisely who is most likely to develop the disease and thus are in need of more immediate intervention.

16 Nov 2008

Previously unknown regulatory step during HIV replication provides potential new target for HIV/AIDS therapy

A previously unknown regulatory step during human immunodeficiency (HIV) replication provides a potentially valuable new target for HIV/AIDS therapy, report researchers at the Salk Institute for Biological Studies and the University of Wisconsin, Madison.

16 Nov 2008

100,000 saved from dying of tuberculosis

Asma Elsony led the tuberculosis programme in Sudan at the same time as she took her doctoral degree under the supervision of Professor Gunnar Bjune of the Department of General Practice and Community Medicine, University of Oslo in Norway.

13 Nov 2008

Analyses of Merck's HIV vaccine 'Step' study

Results from the Step study, a test-of-concept efficacy study of a Merck & Co., Inc. HIV vaccine candidate, were published online in two papers in The Lancet.

12 Nov 2008

State mandates for HPV vaccination unwarranted and unwise

The HPV vaccine, sold as Gardasil in the U.S., is intended to prevent four strains of the human papillomavirus, the most common sexually transmitted infection in the world.

12 Nov 2008

Expert warns it would be ill-advised to mandate HPV vaccinations at this time

Vaccinating girls against the human papillomavirus (HPV) before they are sexually active appears to be successful in protecting them against cervical cancer, however, a Johns Hopkins University researcher and health policy expert warns it would be ill-advised to mandate vaccinations at this time.

12 Nov 2008

Comprehensive assessment of burden of HPV-associated cancers in the U.S.

Professor Vivien Chen, PhD,. Associate Professor Xiao Cheng Wu, MD, PhD and Assistant Professor Edward Peters, DMD, SM, ScD, at LSU Health Sciences Center New Orleans School of Public Health contributed five papers to the largest most comprehensive assessment of the burden of human papillomavirus (HPV)-associated cancers in the United States to date.

11 Nov 2008

Calls for a more flexible approach to vaccine funding

Governments should take a broader perspective - including quality-of-life impacts - when considering whether to fund vaccines, according to a paper from the University of New South Wales (UNSW).

11 Nov 2008

Latest research on diagnosis and treatment of allergic diseases

Researchers are presenting more than 450 abstracts on investigational findings in the diagnosis and treatment of allergic diseases at the ACAAI Annual Meeting in Seattle, Nov. 6-11. Following are highlights of some key studies on asthma.

11 Nov 2008

Cells exhausted from fighting HIV infection can be rescued

Researchers at the University of Toronto and the University of California, San Francisco, have revealed new hope for HIV treatment with the discovery of a way to 'rescue' immune cells that are exhausted from fighting off HIV infection.

11 Nov 2008

1918 Spanish flu records could hold the key to solving future pandemics

Ninety years after Australian scientists began their race to stop the spread of Spanish flu in Australia, University of Melbourne researchers are hoping records from the 1918 epidemic may hold the key to preventing future deadly pandemic outbreaks.

10 Nov 2008

Food allergies are on the rise but effective treatment in the pipeline

Experts in the U.S. say food allergies are on the rise and although strict avoidance is currently the only treatment, new effective therapies are currently being developed.

10 Nov 2008

Flu shots cut the risk of blood clots forming in veins

According to new research by French scientists flu shots may reduce the risk of venous thrombotic embolism.

10 Nov 2008

T-cell-based strategy for HIV-1 vaccines still viable option

The question of whether or not to continue to pursue the development of T-cell-based HIV-1 vaccines has been a source of controversy following last year's widely publicized failure of the field's most promising candidate, a vaccine developed by Merck known as V520.

10 Nov 2008

Scientists engineer immune cells to act as "bionic assassins" that see through HIV's many disguises

HIV is a master of disguise, able to rapidly change its identity and hide undetected in infected cells.

10 Nov 2008

Vaccine News and Research

Latest Vaccine News and Research

Seniors should have the flu jab this winter, say experts

Vaccine-related chronic fatigue syndrome in an individual demonstrating aluminium overload

NCI sponsors Canadian cold/flu remedy trial in leukemia patients

One in four Gulf war veterans suffers from illness caused by toxic exposure

Governments urged to take broader perspective when considering whether to fund vaccines

Researchers say identifying women with HPV types 16, 18 and 45 could improve early intervention to stop cervical cancer

Previously unknown regulatory step during HIV replication provides potential new target for HIV/AIDS therapy

100,000 saved from dying of tuberculosis

Analyses of Merck's HIV vaccine 'Step' study

State mandates for HPV vaccination unwarranted and unwise

Expert warns it would be ill-advised to mandate HPV vaccinations at this time

Comprehensive assessment of burden of HPV-associated cancers in the U.S.

Calls for a more flexible approach to vaccine funding

Latest research on diagnosis and treatment of allergic diseases

Cells exhausted from fighting HIV infection can be rescued

1918 Spanish flu records could hold the key to solving future pandemics

Food allergies are on the rise but effective treatment in the pipeline

Flu shots cut the risk of blood clots forming in veins

T-cell-based strategy for HIV-1 vaccines still viable option

Scientists engineer immune cells to act as "bionic assassins" that see through HIV's many disguises

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in